Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma (Q42290948)
Jump to navigation
Jump to search
scientific article published on 17 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma |
scientific article published on 17 March 2015 |
Statements
1 reference
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma (English)
1 reference
Matthew G Fury
1 reference
Han Xiao
1 reference
Eric J Sherman
1 reference
Shrujal Baxi
1 reference
Stephanie Smith-Marrone
1 reference
Karen Schupak
1 reference
Richard Gewanter
1 reference
Sofia Haque
1 reference
Heiko Schoder
1 reference
Jatin P Shah
1 reference
Nora Katabi
1 reference
Rachel Kurtzman
1 reference
Brynna Lipson
1 reference
Lisa Cox
1 reference
Nancy Y Lee
1 reference
David G Pfister
1 reference
17 March 2015
1 reference
1 reference
38 Suppl 1
1 reference
E566-70
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference